SMTL ID : 2f8i.2 (1 other biounit)

Human transthyretin (TTR) complexed with Benzoxazole

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.54 Å

Oligo State

homo-tetramer

Ligands

4 x 205: 2-(2,6-DICHLOROPHENYL)-1,3-BENZOXAZOLE-6-CARBOXYLIC ACID(Non-covalent)

205.1: 14 residues within 4Å: Chain A: K.15, L.17, A.108, A.109, L.110, S.117 Chain C: L.17, T.106, A.108, A.109, L.110, S.117, T.119 Ligands: 205.3 6 PLIP interactions: 2 interactions with chain A, 4 interactions with chain C Hydrophobic interactions: A:L.17, C:L.17, C:A.108, C:L.110, C:L.110 Salt bridges: A:K.15 205.2: 15 residues within 4Å: Chain B: K.15, L.17, A.108, A.109, L.110, S.117 Chain D: L.17, T.106, A.108, A.109, L.110, S.117, T.119, V.121 Ligands: 205.4 7 PLIP interactions: 2 interactions with chain D, 5 interactions with chain B Hydrophobic interactions: D:L.17, D:A.108, B:K.15, B:L.17, B:L.110, B:L.110 Salt bridges: B:K.15 205.3: 14 residues within 4Å: Chain A: L.17, T.106, A.108, A.109, L.110, S.117, T.119 Chain C: K.15, L.17, A.108, A.109, L.110, S.117 Ligands: 205.1 6 PLIP interactions: 4 interactions with chain A, 2 interactions with chain C Hydrophobic interactions: A:L.17, A:A.108, A:L.110, A:L.110, C:L.17 Salt bridges: C:K.15 205.4: 15 residues within 4Å: Chain B: L.17, T.106, A.108, A.109, L.110, S.117, T.119, V.121 Chain D: K.15, L.17, A.108, A.109, L.110, S.117 Ligands: 205.2 7 PLIP interactions: 5 interactions with chain D, 2 interactions with chain B Hydrophobic interactions: D:K.15, D:L.17, D:L.110, D:L.110, B:L.17, B:A.108 Salt bridges: D:K.15

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Razavi, H. et al., Benzoxazoles as transthyretin amyloid fibril inhibitors: synthesis, evaluation, and mechanism of action. Angew.Chem.Int.Ed.Engl. (2003)

Release Date

2005-12-20

Peptides

Transthyretin: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
A

D
B

Transthyretin

Related Entries With Identical Sequence